Internal Medicine, Hematology & Oncology · Los Angeles, CA
NPI
1114977071
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5901 W Olympic Blvd Ste 505
Los Angeles, CA, 90036
Phone (323) 930-2324
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.8M
259,573 services
Medicare patients, 2024
960
Average age 75
Drug cost, 2024
$8.0M
2,939 prescriptions
Company payments, 2025
$5,097
From 44 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Youram Nassir was code J9263 (injection, oxaliplatin, 0.5 mg), 57,300 times for 30 patients. In total Youram Nassir billed 259,573 services in 113 codes, and Medicare paid $2.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 57,300 | 30 | $0.06 | $3,185 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 28,968 | 172 | $0.07 | $2,142 |
| J1447 Injection, tbo-filgrastim, 1 microgram | Office | 24,901 | 15 | $0.33 | $8,314 |
| Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | Office | 15,901 | 17 | $0.21 | $3,411 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 13,263 | 94 | $0.09 | $1,196 |
| J9267 Injection, paclitaxel, 1 mg | Office | 11,710 | 13 | $0.08 | $897 |
| 96361 Intravenous Infusion, Hydration | Office | 8,306 | 248 | $11.47 | $95K |
| 99233 Hospital E&M - Subsequent | Facility | 6,857 | 371 | $101.92 | $699K |
| 36415 Venipuncture Blood Collection | Office | 6,500 | 758 | $8.62 | $56K |
| J3490 Unclassified drugs | Office | 6,429 | 158 | $0.29 | $1,895 |
| 85025 Blood Count | Office | 6,378 | 745 | $7.61 | $49K |
| 96367 Intravenous Infusion, Hydration | Office | 6,234 | 175 | $26.60 | $166K |
| 99214 Office E&M - Established | Office | 5,952 | 632 | $113.22 | $674K |
| 80048 Clinical Chemistry | Office | 5,520 | 743 | $8.29 | $46K |
| 80076 Clinical Chemistry | Office | 5,217 | 740 | $8.01 | $42K |
By year: 2022 $2.6M for 227,225 services; 2023 $2.8M for 273,985 services; 2024 $2.8M for 259,573 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 6,500 | 758 | $8.62 | $56K |
| 85025 Blood Count | 6,378 | 745 | $7.61 | $49K |
| 80048 Clinical Chemistry | 5,520 | 743 | $8.29 | $46K |
| 80076 Clinical Chemistry | 5,217 | 740 | $8.01 | $42K |
| 82378 Clinical Chemistry | 1,167 | 292 | $18.57 | $22K |
| 84443 Clinical Chemistry | 953 | 560 | $16.44 | $16K |
| 80061 Clinical Chemistry | 626 | 474 | $13.12 | $8,213 |
| 84153 Clinical Chemistry | 600 | 210 | $18.02 | $11K |
| 86304 Immunoassay | 107 | 28 | $20.39 | $2,182 |
| 84403 Clinical Chemistry | 97 | 60 | $25.29 | $2,453 |
Medicare prescription drug claims, 2024
In 2024, the drug Youram Nassir prescribed most often to Medicare patients was Keytruda (Pembrolizumab), with 182 prescriptions and refills. In total Youram Nassir wrote 2,939 Medicare prescriptions that cost $8.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Keytruda Pembrolizumab | 182 | 182 | 21 | $2.0M |
| Zarxio Filgrastim-Sndz | 151 | 151 | 42 | $233K |
| Mirtazapine Generic | 85 | 88 | 47 | $1,286 |
| Gabapentin Generic | 79 | 107 | 42 | $564 |
| Eliquis Apixaban | 65 | 79 | 28 | $48K |
| Rosuvastatin Calcium Generic | 63 | 87 | 33 | $296 |
| Ondansetron Odt Ondansetron | 60 | 62 | 45 | $1,122 |
| Lansoprazole Generic | 59 | 65 | 36 | $760 |
| Neupogen Filgrastim | 56 | 56 | 14 | $97K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 56 | 56 | 23 | $1,149 |
| Amlodipine Besylate Generic | 51 | 90 | 24 | $230 |
| Prochlorperazine Maleate Generic | 50 | 50 | 37 | $874 |
| Procrit Epoetin Alfa | 49 | 49 | 16 | $198K |
| Levofloxacin Generic | 49 | 49 | 39 | $111 |
| Oxycodone Hcl Generic | 44 | 44 | 20 | $765 |
Brand drugs: - claims; generic drugs: 1,849 claims; opioid claims: 240.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Youram Nassir $5,097 ($5,097 in general payments such as food, travel and fees) from 44 companies. The largest payer was Janssen Biotech, Inc. with $582.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 21 | $582 |
| AstraZeneca Pharmaceuticals LP AZN | 20 | $496 |
| E.R. Squibb & Sons, L.L.C. BMY | 35 | $372 |
| Pfizer Inc. PFE | 15 | $313 |
| Merck Sharp & Dohme LLC MRK | 10 | $301 |
| Celgene Corporation BMY | 28 | $293 |
| Incyte Corporation INCY | 14 | $197 |
| Agios Pharmaceuticals, Inc. AGIO | 7 | $184 |
| Genzyme Corporation SNY | 3 | $182 |
| Astellas Pharma US Inc 4503.T | 17 | $177 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.